Hound Partners & Arrow Capital Management Are Buying the Same Stocks

Jonathan Auerbach co-founded long/short equity fund Hound Partners with Scott McLellan in 2004, seeded by Tiger Management. Jonathan Auerbach had been a senior analyst at Ziff Brothers Investments before joining Tiger Management in 2004, when he was put in charge of a new umbrella fund, which became Hound Partners. Auerbach lured Scott McLellan to Tiger to help him run the fund. Prior to that, McLellan worked at Highbridge Capital. In 2007, Scott McLellan left to form Marble Arch Partners with Timothy Jenkins, who had spent three years working at Tiger Management. Jonathan Auerbach’s Hound Partners gained around 16 percent in 2013.

Arrow Capital Management, managed by Mal Serure, is “an alternative asset management firm focused on event-driven value investing, primarily in global public equities,” according to the firm. Mal Serure is a Bear Stearns alum, and Alex von Furstenberg–a former co-portfolio manager with the firm–has since moved on to found Ranger Global Advisors, a family office that manages over $1 billion in assets.

In their most recent 13F filings reflecting activity during the fourth quarter of 2013, the two hedge funds, Hound Partners and Arrow Capital Management, demonstrated some similarity in their holdings, including Valeant Pharmaceuticals International Inc. (NYSE:VRX), Carters Inc. (NYSE:CRI),  Charter Communications Inc. (NASDAQ:CHTR), and Endo Pharmaceuticals Holdings (NASDAQ:ENDP). Other investments owned by both funds include W R Grace & Co. (NYSE:GRA), Transdigm Group Inc. (NYSE:TDG) and Tesoro Corp. (NYSE:TSO). Given the concentrated number of stocks in their portfolios (23 for Hound and 17 for Arrow), we thought the overlap was interesting and wanted to explore some of their common investments a little bit more closely. Hound’s portfolio had a striking similarity with Marble Arch’s investments, which was not surprising given the shared backgrounds of the two funds’ founders. However, there is no similar relationship between Jonathan Auerbach and Mal Serure, which makes their overlapping holdings even more intriguing.

Valeant Pharmaceuticals Intl Inc (NYSE:VRX)

Valeant Pharmaceuticals International Inc. (NYSE:VRX) was the top holding of Hound and second largest of Arrow. Hound maintained its position in the multinational specialty pharmaceutical company during the fourth quarter, while Arrow increased it by 5%. VRX has had a strong run over the past year, as its earnings have been boosted by its recent acquisition of eye care products maker Bausch & Lomb Holdings Inc.

Children apparel maker Carter Inc. (NYSE:CRI) was the second largest equity position of Hound and third largest of Arrow. Hound maintained its stake in the position, while Arrow reduced its stake by 30% during the fourth quarter. The stock has been volatile, with a disappointing earnings report in 3Q13 causing the price to drop precipitously in late October 2013, while a consensus-beating earnings release and forward guidance caused a similar rise in February 2014.

Endo Pharmaceuticals Holdings (NASDAQ:ENDP) was the 14th largest position of Hound and the fifth largest of Arrow. Hound increased its stake by 53% during the fourth quarter, while Arrow’s purchase was a new position. The stock had a great run over the past 12 months, appreciating by 145%, aided by a deal to acquire Canada’s Paladin Labs for $1.6 billion and a plan to re-domicile to Ireland, which will lower its tax rate.

Transdigm Group Inc. (NYSE:TDG) was 11th on the ranking for Hound and 10th for Arrow. Again, the former increased its stake in the aircraft component maker by 13% during the fourth quarter, while the latter’s position was a new purchase. The stock has recovered strongly since bottoming out in August, when it released disappointing earnings and forward guidance.

Disclosures: none.

Recommended reading:

Sandell Asset Management Increases Holding of Bob Evans Farms Inc (BOBE) Shares

Steven Cohen’s SAC Capital Ups Passive Stake in Gogo Inc (GOGO)

Carl Icahn’s Interview on eBay Inc (EBAY)

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!